Navigation Links
Beta blockers and perioperative care: EHJ editorial addresses controversy

Zurich, 7 February 2014. Since the end of 2011 when the scientific work of Professor Don Poldermans was first scrutinized there has been controversy in the medical world about the use of beta blockers in perioperative care.

The recent publication - and retraction for proper peer reviewing and revision - in the European Heart Journal (EHJ) of a paper by Professors Cole and Francis from Imperial College, questioning whether beta blockers in perioperative care could lead to a mortality increase brought the topic back into the public eye.

The EHJ has published an editorial (1) today addressing these questions.

In the editorial, Professors Thomas Lscher, Bernard Gersh, Ulf Landmesser and Frank Ruschitzka highlight, among other points, that

  • The meta analysis is mainly driven by the POISE trial that used very high dosages of metoprolol immediately before surgery

  • Different dosing and starting time of betablockade before surgery may importantly determine outcome

  • A registry published in 2013 in JAMA (2) supports the use of perioperative blockade, at least in non-vascular surgery

  • Until today, only one of Prof Poldermans' manuscripts has been retracted, so the validity of his large beta blocker DECREASE trial published in the NEJM remains uncertain (3)

  • A proper clinical trial is needed in order to assess whether the use of beta blockers starting at a low dose several days before surgery - as has been recommended by the ESC Guidelines of 2007 - might be beneficial or harmful

  • The ESC Task Force led by Professors Steen Dalby Kristensen and Juhani Knuuti, is carefully revising all existing evidence and will present a new version of the ESC Guidelines on "Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery" by this summer. These will try to answer two major issues: 1 Should beta blockers be continued in patients scheduled for surgery who are already on them? 2 Should beta blockers be started in patient undergoing surgery who have never received them previously?

Whether beta blockers in perioperative care are protective, safe or harmful continues to be a subject of debate. The new ESC Guidelines will try to clarify some of the controversial issues. As stated jointly by ACC/AHA/ESC (4), in the meantime, the current position is that "the initiation of beta blockers in patients who will undergo non-cardiac surgery should not be considered routine, but should be considered carefully by each patient's treating physician on a case-by-case basis."


Contact: Céline Colas
European Society of Cardiology

Related medicine news :

1. Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
2. The Future of Perioperative Medicine – Education for Business Managers in Operating Rooms
3. UC Irvine Health Appoints William C. Wilson, MD, as Hospital Director of Critical Care Services, Division of the Department of Anesthesiology & Perioperative Care
4. UC Irvine’s ‘Perioperative Surgical Home’ Improves Clinical Outcomes While Reducing Healthcare Costs
5. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
6. Energy Infusion Meets Skin Care: Introducing Dahryn Silver Gel™
7. Minorities Less Likely to Use Hospice Care: Study
8. Home Elder Care: Buyer, Beware
9. Cost Keeps Many Americans From Good Dental Care: Report
10. The cost of glaucoma care: Small group of patients accounts for large part of costs, study finds
11. Medicare: Barrier to hospice increases hospitalization
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology: